Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of antiretroviral therapy in adults with suppressed HIV infection
ChiCTR1900020750Phase 4Not yet recruiting
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lopinavir + ritonavir, lamivudine, zidovudine, tenofovir, nevirapine and 1 more in human immunodeficiency virus infection (HIV) (2 arms), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Virological breakthrough rate and CD4+ T lymphocyte count. Planned start Feb 2019; status: not yet recruiting.
02
Drugs
lopinavir + ritonavirlamivudinezidovudinetenofovirnevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ChiCTR1900020750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020750.